| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000040063 |
| Receipt No. | R000045682 |
| Scientific Title | Periodical difference of SFA intervention -Multi center retrospective analysis- |
| Date of disclosure of the study information | 2020/04/10 |
| Last modified on | 2020/04/05 (Ver. 1) |
| Basic information | ||
| Public title | Periodical difference of SFA intervention
-Multi center retrospective analysis- |
|
| Acronym | MK4 study | |
| Scientific Title | Periodical difference of SFA intervention
-Multi center retrospective analysis- |
|
| Scientific Title:Acronym | MK4 study | |
| Region |
|
|
| Condition | |||
| Condition | Symptomatic Superficial femoral artery (SFA) atherosclerosis occlusive disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the real-world endovascular treatment therapy for SFA AIOD |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Primary patency rate |
| Key secondary outcomes | Free from target lesion revascularization rate, Amputation free rate, all-cause mortality rate |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | From 2010-2018,
Successfully EVT for SFA lesions Rutherford category 2-4 de novo lesions |
|||
| Key exclusion criteria | Rutherford 5-6
In stent restenosis |
|||
| Target sample size | 2800 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kishiwada Tokushukai Hospital | ||||||
| Division name | Cardiology | ||||||
| Zip code | 595-8522 | ||||||
| Address | 4-27-1,Kamori-cho,Kishiwada City Osaka,Japan | ||||||
| TEL | 072-445-9915 | ||||||
| masahiko-fujihara@themis.ocn.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kishiwada Tokushukai Hospital | ||||||
| Division name | Cardiology | ||||||
| Zip code | 595-8522 | ||||||
| Address | 4-27-1,Kamori-cho,Kishiwada City Osaka,Japan | ||||||
| TEL | 072-445-9915 | ||||||
| Homepage URL | |||||||
| masahiko-fujihara@themis.ocn.ne.jp | |||||||
| Sponsor | |
| Institute | Kishiwada Tokushukai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kishiwada Tokushukai Hospital IRB |
| Address | 4-27-1,Kamori-cho,Kishiwada City Osaka,Japan |
| Tel | 072-445-9915 |
| kenji.nakatani@tokushukai.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 岸和田徳洲会病院、小倉記念病院、関西労災病院、森之宮病院、済生会中津病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 2800 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Multicenter retrospective observational analysis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045682 |